Article citationsMore>>

Hoffmann, M., et al. (2021) SARS-CoV-2 Variant B.1.617 Is Resistant to Bamlanivimab and Evades Antibodies Induced by Infection and Vaccination.
https://doi.org/10.1101/2021.05.04.442663

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top